Department of Biochemistry, Benjamin S. Carson (Snr.) School of Medicine, Babcock University, Ilishan-Remo, Ogun State, PMB, 21244 Ikeja, Nigeria.
Biomed Pharmacother. 2017 Feb;86:95-101. doi: 10.1016/j.biopha.2016.11.145. Epub 2016 Dec 12.
Alstonia boonie de Wild is an ethnomedical plant used as therapy against inflammatory disorders. This study evaluated the most active anti-inflammatory and anti-oxidant fraction of A. boonei leaves using in vitro and in vivo models. Quantitative phytochemical analysis, anti-protein denaturation and hypotonicity-induced hemolysis of human red blood cell membrane (HRBC), radical scavenging activity assays, carrageenan and formaldehyde-induced inflammation models were carried out. Results showed that aqueous and ethyl acetate fractions of 70% methanol extract of A. boonie leaves contained high quantities of total phenolic and flavonoid compounds compared with hexane and butanol fractions. Aqueous fraction of A. boonie leaves significantly (P<0.05) inhibited heat-induced protein denaturation, stabilized hypotonicity-induced hemolysis of HRBC, scavenged DPPH, NO and HO radicals in a concentration-dependent manner compared with other fractions in vitro. In addition, orally administered 50-250-mg/kg body weight (b.w.) aqueous fraction of A. boonei leaves suppressed carrageenan-induced rat paw edema thickness by 74.32%, 79.22% and 89.86% respectively at 6th h in a dose-dependent manner comparable with animals treated with standard diclofenac sodium (88.69%) in vivo. Furthermore, investigation of formaldehyde-induced inflammation in rats showed that 50-250 mg/kg b.w. aqueous fraction of A. boonei reduced plasma alanine aminotransferase and aspartate aminotransferase activities. Aqueous fraction of A. boonei also suppressed eosinophils, monocytes and basophils, total white blood cell, total platelet, neutrophil and lymphocyte counts and modulated plasma lipid profile compared with control group. Aqueous fraction of A. boonei leaves exhibited substantial active anti-inflammatory and antioxidant activities. Hence, an aqueous fraction of A. boonei leaves could be channeled towards pharmaceutical drug development. In addition, this study provided scientific insight to account for the traditional use of A. boonei leaves in ethnomedical practice.
阿尔斯通博尼德怀尔德是一种被民族医学用作治疗炎症性疾病的植物。本研究使用体外和体内模型评估了阿尔斯通博尼叶最活跃的抗炎和抗氧化部分。进行了定量植物化学分析、抗蛋白变性和人红细胞膜(HRBC)低渗诱导溶血、自由基清除活性测定、角叉菜胶和甲醛诱导炎症模型。结果表明,与正己烷和正丁醇部分相比,70%甲醇提取物的水和乙酸乙酯部分含有高量的总酚类和类黄酮化合物。与其他部分相比,阿尔斯通博尼叶的水部分在体外显著(P<0.05)抑制热诱导的蛋白变性,稳定 HRBC 的低渗诱导溶血,以浓度依赖的方式清除 DPPH、NO 和 HO 自由基。此外,口服 50-250mg/kg 体重(b.w.)的阿尔斯通博尼叶水部分在第 6 小时以剂量依赖性方式抑制角叉菜胶诱导的大鼠足肿胀厚度,分别为 74.32%、79.22%和 89.86%,与用标准双氯芬酸钠(88.69%)治疗的动物相当体内。此外,对甲醛诱导的大鼠炎症的研究表明,50-250mg/kg b.w.的阿尔斯通博尼叶水部分降低了血浆丙氨酸氨基转移酶和天冬氨酸氨基转移酶的活性。与对照组相比,阿尔斯通博尼叶的水部分还抑制嗜酸性粒细胞、单核细胞和嗜碱性粒细胞、总白细胞、总血小板、中性粒细胞和淋巴细胞计数,并调节血浆脂质谱。阿尔斯通博尼叶的水部分表现出显著的抗炎和抗氧化活性。因此,阿尔斯通博尼叶的水部分可用于药物开发。此外,本研究为传统上使用阿尔斯通博尼叶提供了科学依据民族医学实践。